Im Cannabis Corp
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and cannabis extracts under the IMC, BLKMT, WAGNERS, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Tel Aviv, Israel.
Im Cannabis Corp (IMCC) - Net Assets
Latest net assets as of September 2025: $4.30 Million USD
Based on the latest financial reports, Im Cannabis Corp (IMCC) has net assets worth $4.30 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($44.33 Million) and total liabilities ($40.03 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $4.30 Million |
| % of Total Assets | 9.71% |
| Annual Growth Rate | 6.91% |
| 5-Year Change | -75.05% |
| 10-Year Change | N/A |
| Growth Volatility | 398.97 |
Im Cannabis Corp - Net Assets Trend (2003–2024)
This chart illustrates how Im Cannabis Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Im Cannabis Corp (2003–2024)
The table below shows the annual net assets of Im Cannabis Corp from 2003 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $3.15 Million | -77.04% |
| 2023-12-31 | $13.70 Million | -42.43% |
| 2022-12-31 | $23.80 Million | -88.39% |
| 2021-12-31 | $204.94 Million | +1525.26% |
| 2020-12-31 | $12.61 Million | -51.70% |
| 2019-12-31 | $26.11 Million | +12263.69% |
| 2018-12-31 | $-214.65K | +53.02% |
| 2017-12-31 | $-456.84K | -5.78% |
| 2016-12-31 | $-431.87K | -3.78% |
| 2015-12-31 | $-416.12K | -12.31% |
| 2014-12-31 | $-370.51K | -26.45% |
| 2013-12-31 | $-293.01K | -85.05% |
| 2012-12-31 | $-158.34K | -101.68% |
| 2011-12-31 | $9.44 Million | +0.71% |
| 2010-12-31 | $9.37 Million | +3.93% |
| 2009-12-31 | $9.02 Million | +41.87% |
| 2008-12-31 | $6.36 Million | +166.07% |
| 2007-12-31 | $2.39 Million | +65.16% |
| 2006-12-31 | $1.45 Million | +76.56% |
| 2005-12-31 | $819.27K | -19.49% |
| 2004-12-31 | $1.02 Million | +31.65% |
| 2003-12-31 | $772.97K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Im Cannabis Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 24607383300.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $265.00 Million | 5054.36% |
| Other Comprehensive Income | $-1.26 Million | -24.13% |
| Other Components | $447.00K | 8.53% |
| Total Equity | $5.24 Million | 100.00% |
Im Cannabis Corp Competitors by Market Cap
The table below lists competitors of Im Cannabis Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Progressive Impact Corporation Bhd
KLSE:7201
|
$1.79 Million |
|
BRDRIDG FNCL SOL
BE:5B9
|
$1.79 Million |
|
AGNICO EAGLE MINES - Dusseldorf Stock Exchang
DU:AE9
|
$1.79 Million |
|
Tellusgruppen AB
ST:TELLUS
|
$1.80 Million |
|
HAVILA KYSTRUTEN AS NK 1
F:6FZ
|
$1.79 Million |
|
Archon Minerals Ltd
V:ACS
|
$1.79 Million |
|
AEROVIRONMENT (JPX.SG)
STU:JPX
|
$1.79 Million |
|
Osmosun S.A.
F:V05
|
$1.79 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Im Cannabis Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 14,469,000 to 5,243,000, a change of -9,226,000 (-63.8%).
- Net loss of 10,585,000 reduced equity.
- New share issuances of 944,000 increased equity.
- Other comprehensive income decreased equity by 1,360,000.
- Other factors increased equity by 1,775,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-10.59 Million | -201.89% |
| Share Issuances | $944.00K | +18.0% |
| Other Comprehensive Income | $-1.36 Million | -25.94% |
| Other Changes | $1.77 Million | +33.85% |
| Total Change | $- | -63.76% |
Book Value vs Market Value Analysis
This analysis compares Im Cannabis Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.26x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.01x to 0.26x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2003-12-31 | $88.54 | $0.58 | x |
| 2004-12-31 | $103.62 | $0.58 | x |
| 2005-12-31 | $71.10 | $0.58 | x |
| 2006-12-31 | $98.83 | $0.58 | x |
| 2007-12-31 | $121.40 | $0.58 | x |
| 2008-12-31 | $227.13 | $0.58 | x |
| 2009-12-31 | $264.89 | $0.58 | x |
| 2010-12-31 | $210.35 | $0.58 | x |
| 2011-12-31 | $204.40 | $0.58 | x |
| 2012-12-31 | $77.15 | $0.58 | x |
| 2013-12-31 | $65.94 | $0.58 | x |
| 2014-12-31 | $221.45 | $0.58 | x |
| 2015-12-31 | $220.56 | $0.58 | x |
| 2016-12-31 | $220.27 | $0.58 | x |
| 2017-12-31 | $210.30 | $0.58 | x |
| 2018-12-31 | $3.61 | $0.58 | x |
| 2019-12-31 | $6.63 | $0.58 | x |
| 2020-12-31 | $2.88 | $0.58 | x |
| 2021-12-31 | $33.99 | $0.58 | x |
| 2022-12-31 | $19.72 | $0.58 | x |
| 2023-12-31 | $6.77 | $0.58 | x |
| 2024-12-31 | $2.23 | $0.58 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Im Cannabis Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -201.89%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -19.59%
- • Asset Turnover: 1.38x
- • Equity Multiplier: 7.47x
- Recent ROE (-201.89%) is below the historical average (-84.80%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2003 | -86.16% | 0.00% | 0.00x | 1.14x | $-743.30K |
| 2004 | -0.51% | 0.00% | 0.00x | 1.13x | $-106.98K |
| 2005 | -102.16% | 0.00% | 0.00x | 1.35x | $-918.93K |
| 2006 | -42.24% | 0.00% | 0.00x | 1.16x | $-755.65K |
| 2007 | -31.89% | 0.00% | 0.00x | 1.19x | $-1.00 Million |
| 2008 | -22.24% | 0.00% | 0.00x | 1.01x | $-2.05 Million |
| 2009 | -14.68% | 0.00% | 0.00x | 1.03x | $-2.23 Million |
| 2010 | -7.78% | 0.00% | 0.00x | 1.10x | $-1.53 Million |
| 2011 | -6.00% | 0.00% | 0.00x | 1.12x | $-1.39 Million |
| 2012 | -161.05% | 0.00% | 0.00x | 0.03x | $-5.71 Million |
| 2013 | -7.10% | 0.00% | 0.00x | 0.01x | $-549.84K |
| 2014 | -0.33% | 0.00% | 0.00x | 0.00x | $-1.18 Million |
| 2015 | -0.40% | 0.00% | 0.00x | 0.00x | $-1.18 Million |
| 2016 | -0.14% | 0.00% | 0.00x | 0.00x | $-1.15 Million |
| 2017 | -1.10% | -2.84% | 480.48x | 0.00x | $-1.26 Million |
| 2018 | 16.53% | 32.38% | 140.45x | 0.00x | $664.80K |
| 2019 | -29.57% | -80.36% | 0.29x | 1.25x | $-9.76 Million |
| 2020 | -258.61% | -180.60% | 0.42x | 3.43x | $-29.81 Million |
| 2021 | -8.83% | -52.16% | 0.12x | 1.43x | $-37.89 Million |
| 2022 | -833.88% | -347.64% | 0.90x | 2.68x | $-191.16 Million |
| 2023 | -65.64% | -19.46% | 1.00x | 3.37x | $-10.94 Million |
| 2024 | -201.89% | -19.59% | 1.38x | 7.47x | $-11.11 Million |
Industry Comparison
This section compares Im Cannabis Corp's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Im Cannabis Corp (IMCC) | $4.30 Million | -86.16% | 9.30x | $1.79 Million |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |